In vitro pharmacological properties of A-349821, a novel non-imidizole histamine H3 receptor antagonist

被引:0
|
作者
Baranowski, JL
Krueger, KM
Miller, TR
Kang, CH
Witte, DG
Yao, BB
Faghih, R
Bennani, Y
Dwight, W
Esbenshade, TA
Hancock, AA
机构
[1] Abbott Labs, R4MN, Abbott Pk, IL 60064 USA
[2] Athersys Inc, Chem, Cleveland, OH USA
来源
FASEB JOURNAL | 2003年 / 17卷 / 04期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:A208 / A208
页数:1
相关论文
共 50 条
  • [1] Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist
    Esbenshade, TA
    Fox, GB
    Krueger, KM
    Baranowski, JL
    Miller, TR
    Kang, CH
    Denny, LI
    Witte, DG
    Yao, BB
    Pan, JB
    Faghih, R
    Bennani, YL
    Williams, M
    Hancock, AA
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (05) : 933 - 945
  • [2] Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand
    Witte, David G.
    Yao, Betty Bei
    Miller, Thomas R.
    Carr, Tracy L.
    Cassar, Steven
    Sharma, Rahul
    Faghih, Ramin
    Surber, Bruce W.
    Esbenshade, Timothy A.
    Hancock, Arthur A.
    Krueger, Kathleen M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (05) : 657 - 670
  • [3] Use of the H3 receptor antagonist radioligand [3H]-A-349821 to reveal in vivo receptor occupancy of cognition enhancing H3 receptor antagonists
    Miller, T. R.
    Milicic, I.
    Bauch, J.
    Du, J.
    Surber, B.
    Browman, K. E.
    Marsh, K.
    Cowart, M.
    Brioni, J. D.
    Esbenshade, T. A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (01) : 139 - 149
  • [4] Pharmacological effects of a histamine H3 receptor antagonist to neuropathic pain
    Yoshikawa, Takeo
    Matsuzawa, Takuro
    Mogi, Asuka
    Mogilevskaya, Maria
    Nakamura, Tadaho
    Yanai, Kazuhiko
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S187 - S187
  • [5] Radiosynthesis of a Histamine H3 receptor antagonist:: In vitro and in vivo evaluation
    Airaksinen, Ann J.
    Jablonowski, J. A.
    van der Mey, M.
    Barbier, A. J.
    Klok, R. P.
    Verbeek, J.
    Schuit, R. C.
    Herscheid, J. D. M.
    Lammertsma, A. A.
    Carruthers, B. I.
    Leysen, J. E.
    Windhorst, A. D.
    NEUROIMAGE, 2006, 31 : T46 - T46
  • [6] In vitro pharmacological properties of two novel non-imidazole H3 receptor (H3R) antagonists
    B. B. Yao
    D. G. Witte
    T. R. Miller
    K. M. Krueger
    T. L. Carr
    C. H. Kang
    R. Faghih
    Y. L. Bennani
    T. A. Esbenshade
    A. A. Hancock
    Inflammation Research, 2003, 52 (Suppl 1) : s45 - s46
  • [7] In vitro pharmacological properties of two novel non-imidazole H3 receptor (H3R) antagonists
    Yao, BB
    Witte, DG
    Miller, TR
    Krueger, KM
    Carr, TL
    Kang, CH
    Faghih, R
    Bennani, YL
    Esbenshade, TA
    Hancock, AA
    INFLAMMATION RESEARCH, 2003, 52 : S45 - S46
  • [8] Pharmacological Properties and Procognitive Effects of ABT-288, a Potent and Selective Histamine H3 Receptor Antagonist
    Esbenshade, Timothy A.
    Browman, Kaitlin E.
    Miller, Thomas R.
    Krueger, Kathleen M.
    Komater-Roderwald, Victoria
    Zhang, Min
    Fox, Gerard B.
    Rueter, Lynne
    Robb, Holly M.
    Radek, Richard J.
    Drescher, Karla U.
    Fey, Thomas A.
    Bitner, R. Scott
    Marsh, Kennan
    Polakowski, James S.
    Zhao, Chen
    Cowart, Marlon D.
    Hancock, Arthur A.
    Sullivan, James P.
    Brioni, Jorge D.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 343 (01): : 233 - 245
  • [9] A scalable synthesis of a histamine H3 receptor antagonist
    Mani, NS
    Jablonowski, JA
    Jones, TK
    JOURNAL OF ORGANIC CHEMISTRY, 2004, 69 (23): : 8115 - 8117
  • [10] Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist
    Hancock, AA
    Bennani, YL
    Bush, EN
    Esbenshade, TA
    Faghih, R
    Fox, GB
    Jacobson, P
    Knourek-Segel, V
    Krueger, KM
    Nuss, ME
    Pan, JB
    Shapiro, R
    Witte, DG
    Yao, BB
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 487 (1-3) : 183 - 197